×
BioLife Solutions Receivables 2010-2025 | BLFS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
BioLife Solutions receivables from 2010 to 2025. Receivables can be defined as the total amount of collectibles for a company
View More
BioLife Solutions Receivables 2010-2025 | BLFS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
BioLife Solutions receivables from 2010 to 2025. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$226.7B
Boston Scientific (BSX)
$152.7B
Stryker (SYK)
$145.9B
EssilorLuxottica (ESLOY)
$145.2B
Medtronic (MDT)
$119B
Lonza Group Ag (LZAGY)
$48.3B
Haleon (HLN)
$43.4B
ResMed (RMD)
$41.9B
Agilent Technologies (A)
$33.6B
GE HealthCare Technologies (GEHC)
$33.4B
Terumo (TRUMY)
$27.9B
Koninklijke Philips (PHG)
$26.4B
Insulet (PODD)
$22.7B
Zimmer Biomet Holdings (ZBH)
$20.3B
Smith & Nephew SNATS (SNN)
$15.9B
Baxter (BAX)
$12.1B
Sunny Optical Technology (SNPTF)
$10.8B
Demant (WILYY)
$8.1B
Bio-Rad Laboratories (BIO)
$7.7B
Lantheus Holdings (LNTH)
$3.8B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
Envista Holdings (NVST)
$3.5B
Prestige Consumer Healthcare (PBH)
$3.2B
Perrigo (PRGO)
$3.2B
ICU Medical (ICUI)
$3B
Haemonetics (HAE)
$2.6B
LeMaitre Vascular (LMAT)
$2.2B
Curaleaf Holdings (CURLF)
$1.9B
AtriCure (ATRC)
$1.8B
QuidelOrtho (QDEL)
$1.8B